Assignee

Kaleido Biosciences, Inc.

Patents = 9

Trademarks = 3

Forward Citations = 67

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

12 inventors (with patents filed for the assignee):

Kaleido Biosciences is a clinical-stage healthcare company pioneering the development of a new class of medicines based on the potential of the human microbiome. Kaleido's Microbiome Metabolic Therapy platform is designed to optimize the intestinal microbiome to treat disease and improve human health.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com